Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation CADTH. Tranexamic acid for the management of bleeding: a review of the clinical effectiveness and guidelines. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). Rapid Response - Summary with Critical Appraisal. 2013 Authors' conclusions Overall, there is evidence to suggest treatment with tranexamic acid reduces mortality from trauma related bleeding. In addition, subgroup analysis suggests treatment with 3 hours of trauma is associated with decreased mortality. However, treatment beyond three hours of trauma may be associated with an increased risk of death. Indexing Status Subject indexing assigned by CRD MeSH Humans; Survival Rate; Time Factors; Tranexamic Acid Language Published English Country of organisation Canada English summary An English language summary is available. Address for correspondence Canadian Agency for Drugs and Technologies in Health (CADTH), 865 Carling Avenue, Suite 600, Ottawa, Ontario Canada, K1S 5S8 Email: requests@cadth.ca AccessionNumber 32014000137 Date abstract record published 24/01/2014 |